TNFSF11 and Alzheimer disease: We also showed that the expression and/or activation of multiple signaling molecules, including c-Fos, NFATc1, ERK and NF-κB, during RANKL-induced osteoclastogenesis, are also down-regulated by AD treatment (Figure 6).